Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factor 

Authors: Sophie Liabeuf, Vesna Pešić, Goce Spasovski, Romaldas Maciulaitis, Mickaël Bobot, Ana Farinha, Carsten A Wagner, Robert J Unwin, Giovambattista Capasso, Inga Arune Bumblyte, 

Gaye Hafez, CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target)

People living with chronic kidney disease (CKD) frequently suffer from mild cognitive impairment and/or other neurocognitive disorders. This review in two parts will focus on adverse drug reactions resulting in cognitive impairment as a potentially modifiable risk factor in CKD patients. 

View publication here.

Latest Updates

STSM

Fifth Call for Short-Term Scientific Mission

Fifth Call for Short-Term Scientific Mission (STSM) applications within the COST Action “Cognitive decline in Nephro-Neurology: European Cooperative Target (CONNECT)” Deadline for submission: April 13th, 2024

Read More
Publications

Efficacy of erythropoietin as a neuroprotective agent in CKD-associated cognitive dysfunction: A literature systematic review

Authors: Michelangela Barbieri, Paolo Chiodini, Piergiacomo Di Gennaro, Gaye Hafez, Sophie Liabeuf, Jolanta Malyszko, Laila-Yasmin Mani, Francesco Mattace Raso, Marion Pepin, Norberto Perico, Mariadelina Simeoni, Carmine Zoccali, Giovanni Tortorella, Annalisa Capuano, Giuseppe Remuzzi, Giovambattista Capasso, Giuseppe Paolisso, on behalf of CONNECT Action (Cognitive Decline in Nephro-Neurology European Cooperative Target) collaborators Patients with chronic kidney disease (CKD) often experience

Read More
//